Making Science Group (MAKS) Q4 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 2025 earnings summary
2 Oct, 2026Executive summary
Achieved €374M in revenue for FY 2025, up 36% year-over-year, driven by international expansion and growth in service activity.
Recurring EBITDA remained stable at €14M, reflecting investments in talent and geographic expansion.
Significant international growth, with new offices in Brazil, Argentina, Germany, and the Netherlands, and a joint venture in Germany.
Sale of the Cloud and Cybersecurity unit (BL2) to Lutech, focusing on core digital marketing and AI technology areas.
Recognized for innovation and as a top employer, with awards from YouTube, Google, and El Mundo.
Financial highlights
Revenue increased by 36% to €374M in FY 2025 compared to FY 2024.
Gross margin rose 5% to €74.8M, with profitability maintained around 20%.
Core business revenue grew 38% to €363.3M, with gross margin up 7.7% to €72.2M.
International segment revenue surged 70% to €216M, with recurring EBITDA up 24% to €5.2M.
E-commerce and product investments saw a 10% revenue decline and a 54% drop in recurring EBITDA.
Outlook and guidance
2026 expected to deliver profitable, sustained growth, leveraging AI-driven products and regional hubs.
Continued international expansion and investment in AI development planned.
Latest events from Making Science Group
- H1 growth and agentic AI underpin H2 international expansion.MAKS
Global Markets Forum Conference - Revenue up 12.8% and Recurring EBITDA up 7.2%, driven by U.S. and AI segment growth.MAKS
Q2 2026 - Record Q1 2025 growth driven by AI innovation and international expansion, targeting €370M revenue.MAKS
Investor Presentation - Strong growth, AI innovation, and global expansion drive leadership in digital acceleration.MAKS
Investor day 2026 presentation - Q1 2026 revenue up 20% year-over-year, led by Digital Agency and a €2M dividend paid.MAKS
Q1 2026 - H1 2025 revenue up 39.9% to €174.6M; recurring EBITDA reached €7.7M; guidance reaffirmed.MAKS
Q2 2025 - Recurring EBITDA nearly doubled in H1 2024, driven by strong growth and operational leverage.MAKS
Q2 2024 - Recurring EBITDA up 94% to €10.6M in 9M 2024, with robust growth and 2024 guidance reaffirmed.MAKS
Q3 2024 - 2024 saw 16% revenue growth and 71% EBITDA growth, with strong international momentum.MAKS
Q4 2024